| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |